Specifically, because a high TRC score is associated with TP53 and DNA damage–related genes alterations, it could be used to identify high-risk patients with MM who may benefit from a G4 stabilizer treatment to improve their response to conventional treatments. Here, TP53 is linked to Miyoshi myopathy.